Evidence map›Paper›PMID 31643029›Full record

ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2019

Antibacterial spectrum of human omentum and differential expression of beta defensins.

Meenu Srivastava, Abhijit Chandra, Jyotsna Agarwal, Rahul Rahul, Jaya Nigam, Devendra Parmar, Leena Khare Satyam

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Meenu SrivastavaDepartment of Surgical Gastroenterology, King George's Medical University, Lucknow, 226 003, India.
Abhijit ChandraDepartment of Surgical Gastroenterology, King George's Medical University, Lucknow, 226 003, India. abhijitchandra@hotmail.com.ORCID http://orcid.org/0000-0002-3940-7428
Jyotsna AgarwalDepartment of Microbiology, King George's Medical University, Lucknow, 226 003, India.
Rahul RahulDepartment of Surgical Gastroenterology, King George's Medical University, Lucknow, 226 003, India.
Jaya NigamDepartment of Surgical Gastroenterology, King George's Medical University, Lucknow, 226 003, India.
Devendra ParmarDevelopmental Toxicology Division, Indian Institute of Toxicology Research, Lucknow, 226 001, India.
Leena Khare SatyamCell and Molecular Biology Department, Aurigene Discovery Technologies Limited, Bangalore, 560 100, India.
King George's Medical University · INAurigene Discovery Technologies (India) · INIndian Institute of Toxicology Research · IN

Funding

Council of Science and Technology, U.P. CST/SERPD/B/619
6 · The paper itself

Abstract

backgroundHuman β defensins (hBD1 and hBD2) are cationic, cysteine-rich peptides and form an integral part of the mammalian innate immune system. hBD1 is constitutively expressed in epithelial cells, whereas hBD2 increases in response to bacterial infection. Human omentum is known for its anti-inflammatory properties and also possesses an antibacterial activity of its own. We hypothesized that antimicrobial peptides, β defensins, may govern host defense mechanism in the microbe-rich environment of the peritoneal cavity. Therefore, we analyzed the expression of hBD1 and hBD2 in omentum tissue in vivo and also studied the antibacterial activity of omentum against common pathogens. METHODOLOGY: Omentum tissues were obtained from 30 patients (15 cases and 15 controls). Real-time polymerase chain reaction (PCR) was used to evaluate the mRNA expression of hBD1 and hBD2. Protein quantification was done using Western blotting technique. Antibacterial susceptibility was performed to check the antibacterial activity of omentum.

resultSignificantly higher expression of hBD2 was observed in cases compared to controls at both the transcriptional and translational levels. In comparison with an array of antibiotics, activated omentum also showed antibacterial property even at lower concentration of its extract.

conclusionOmentum directly responds to bacterial infection, which may be due to differential expression of hBD1 and hBD2 in human omental tissue. These peptides (hBD1 and hBD2) may be an ideal candidate for novel antibiotic class with a broad-spectrum activity.

Indexed as

Anti-Bacterial AgentsBacterial Infectionsbeta-DefensinsCase-Control StudiesHumansOmentumRNA, MessengerAnti-Bacterial Agentsbeta-DefensinsDEFB1 protein, humanDEFB4A protein, humanRNA, MessengerAntibacterial spectrumhBD1hBD2OmentumReal-time PCR

Identifiers

PMID31643029
OpenAlexW2982270271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.